MIRAGLIA, Niccolò,BIANCHI, Davide,VALOTI, Ermanno,TRENTIN, Antonella,TRILLI, Antonio,BUSIELLO, Immacolata,AGOSTINETTO, Marco,BAZZA, Paola,VALETTI, Marco
申请号：
DK13728982
公开号：
DK2852437T3
申请日:
2013.05.22
申请国别(地区):
DK
年份:
2016
代理人:
摘要：
Disclosed is a low-molecular-weight (1000-5000 daltons) chondroitin sulphate (CS) produced by chemical sulphation and subsequent depolymerisation of a non-sulphated chondroitin backbone obtained with biotechnology techniques. The CS described is substantially monosulphated, mainly at the 6-position, with very little sulphation at the 4-position, and with a mono/disulphated disaccharide ratio and charge density similar to those of natural CS. Said biotechnological chondroitin 6-sulphate (C6S) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.
